stocksKPL
KPL

Kwality Pharmaceuticals Ltd.

2,672.50-73.0 (-2.66%)
3 Jul, 3:30 PM

Annual Reports and Financial Documents

Kwality Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20162017201820192020202120222023202420252026
Annual ReportsFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Kwality Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  • Resignation of Director2 Jun 2026
    Announcement under Regulation 30 (LODR)-Resignation of Director
    Resignation of Mr. Kartik Kapur, Independent Director of the Company.
  • Change in Management2 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Mr. Swanith Kapoor as Additional (Non-Executive, Independent) Director and Resignation of Mr. Kartik Kapur, Independent Director of the Company.
  • Reg.24(A)-Annual Secretarial Compliance30 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for the year ended 31-03-2026 is enclosed herewith
  • Analyst / Investor Meet28 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio recording of quarterly earning conference call
  • Newspaper Publication22 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Audited Financial Results for the quarter and year ended March 31, 2026.
  • Outcome of Board Meeting19 May 2026
    Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March, 2026
    Audited Financial Results for the quarter and year ended 31st March, 2026
  • Analyst / Investor Meet14 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Analysts/Investors Conference Call to be held on May 19, 2026 at 5:00 P.M. to discuss Q4 FY26 financial results.
  • Board Meeting8 May 2026
    Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31, 2026
    Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Standalone & Consolidated ....
  • Credit Rating8 May 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Intimation of Revision in Credit Rating
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A30 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended March 31, 2026
  • Postal Ballot30 Mar 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    outcome of postal ballot is attached herewith
  • Postal Ballot30 Mar 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Scrutinizer Report for Postal Ballot
  • Closure of Trading Window26 Mar 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  • General10 Mar 2026
    Update On Bioequivalence (BE) Program - Successful Completion Of Phase 1 By Kwality Pharmaceuticals Ltd.
    Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Updation on Bioequivalence (BE) Program- Successful Completion of Phase 1 by ....
  • Analyst / Investor Meet5 Mar 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of Analysts/Institutional Investors Meeting to be held on March 12, 2026 through an in-person Site Visit.
  • Analyst / Investor Meet5 Mar 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of Analysts/ Institutional Investors Meeting to be held on March 10, 2026 at 4:00 P.M.
  • Newspaper Publication27 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Postal Ballot Notice and E-voting Information
  • Postal Ballot26 Feb 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    Postal Ballot Notice Dtd February 21, 2026

Frequently Asked Questions

Where can I download the annual report of Kwality Pharmaceuticals Ltd.?
Annual reports of Kwality Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Kwality Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Kwality Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Kwality Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Kwality Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Kwality Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Kwality Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Kwality Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Kwality Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Kwality Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Kwality Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Kwality Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Kwality Pharmaceuticals Ltd. is INE552U01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Kwality Pharmaceuticals Ltd. listed?
Kwality Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is KPL and the BSE code is -.
Where can I find the shareholding pattern of Kwality Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Kwality Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Kwality Pharmaceuticals Ltd. on Sharpely?
Share price data for Kwality Pharmaceuticals Ltd. is updated as of 3 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.